Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection

Despite the success of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) vaccines, there remains a clear need for new classes of preventatives for respiratory viral infections due to vaccine hesitancy, lack of sterilizing immunity, and for at‐risk patient populations, including the immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanover, Daryll, Zurla, Chiara, Peck, Hannah E., Orr‐Burks, Nichole, Joo, Jae Yeon, Murray, Jackelyn, Holladay, Nathan, Hobbs, Ryan A., Jung, Younghun, Chaves, Lorena C. S., Rotolo, Laura, Lifland, Aaron W., Olivier, Alicia K., Li, Dapeng, Saunders, Kevin O., Sempowski, Gregory D., Crowe, James E., Haynes, Barton F., Lafontaine, Eric R., Hogan, Robert J., Santangelo, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731714/
https://www.ncbi.nlm.nih.gov/pubmed/36316224
http://dx.doi.org/10.1002/advs.202202771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731714/
https://www.ncbi.nlm.nih.gov/pubmed/36316224
http://dx.doi.org/10.1002/advs.202202771

Ejemplares similares